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Drug-induced death of leukaemic cells after G/M arrest:
higher order DNA fragmentation as an indicator of
mechanism
RJ Sleiman, DR Catchpoole* and BW Stewart
Children's Cancer Research Institute, University of New South Wales, Sydney Children's Hospital, Sydney 2031, Australia
Summary Many reports have documented apoptotic death in different cell types within hours of exposure to cytotoxic drugs; lower drug
concentrations may cause cell cycle arrest at G/M and subsequent death, which has been distinguished from 'classic' apoptosis. We have
analysed etoposide-induced cell death in two lymphoblastoid T-cell lines, CCRF-CEM and MOLT-4, specifically in relation to DNA cleavage
as indicated by pulse-field gel and conventional electrophoresis. High (5,M) concentration etoposide causes 50-kb cleavage of DNA that
occurs at the same time as apoptotic morphology and internucleosomal cleavage. At lower concentrations (0.5-0.05 ,UM), sequential change
may be discerned with altered gene expression being similar to that at high dose, but preceding cell cycle arrest and 50-kb cleavage. These
last changes, in turn, clearly precede internucleosomal fragmentation of DNA, vital dye staining and morphological evidence cell death. The
pattern of higher order fragmentation constitutes a sensitive indicator of commitment to cell death in these cells. Morphological evidence of
cell death is associated with internucleosomal fragmentation in one of the lines, but the pattern of 50-kb DNA cleavage provides the clearest
evidence of commonality in death processes occurring at low and high drug concentration.
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The term 'apoptosis' is reasonably equated with physiological cell
death during immunological selection and biological development
(Wyllie, 1987; Allen et al, 1993). It is also recognized that this
mode of cell death is induced by certain markedly non-physiolog-
ical stimuli exemplified by radiation and certain drugs and
specifically including most agents used in cancer chemotherapy
(Hickman, 1992; Sachs and Lotem, 1993; da Silva et al, 1996). In
the laboratory, induction of apoptosis by drugs has facilitated
identification of processes associated with cell death, and of these
internucleosomal fragmentation of DNA has been pre-eminent
(Barry et al, 1990; Stewart, 1994). This effect is induced by a
multiplicity of agents thereby providing evidence of a common
pathway considered to be initiated by drug-target interaction and
to culminate in cell death (Lennon et al, 1991; Marks and Fox,
1991). Accordingly, internucleosomal fragmentation of DNA,
usually detected as DNA ladders after conventional agarose gel
electrophoresis, has been perceived as the hallmark of apoptosis
(Compton, 1992). However, the biological significance accorded
to internucleosomal fragmentation of DNA is changing from the
perception of an early indicator (Barry and Eastman, 1992; Smith
et al, 1992), to a molecular change concurrent with morphological
evidence ofcell death (Lazebnik et al, 1995) and denoted by Vaux
and Strasser (1996) as a 'post-mortem' event. Moreover, some cell
populations do not exhibit ladders after drug treatment (Bertrand
et al, 1991; Hotz et al, 1992; Falcieri et al, 1993). Other studies,
however, indicate the absence of ladders when cell death is not
immediate, but, in response to lesser concentrations, occurs 24 h
Received 10 February 1997
Revised 10 June 1997
Accepted 11 June 1997
Correspondence to: BW Stewart
or more after the addition of the drug (Ormerod et al, 1994;
Bonelli et al, 1996).
Many, perhaps most, studies of cell death induced by anti-
cancerdrugs have involved cell lines exposed to a sufficiently high
drug concentration that has an immediate effect, i.e. cause cell
death within 8 h or less. Both apoptic morphology and internucle-
osomal fragmentation of DNA may be evident, the term 'classic
apoptosis' being used. Although cytotoxic drugs commonly cause
G2/M cell cycle arrest (Rao and Rao, 1976; Chow and Ross, 1987),
the same agents, when used at concentrations that cause cell death
within hours, result inGI arrest (Chen et al, 1995; Dou et al, 1995;
An and Dou, 1996). G, arrest is intimately associated with func-
tional p53 (Lowe et al, 1993), and the role of this gene in medi-
ating drug-induced apoptosis is clear and has been implicated in
determining response to therapy (Lowe et al, 1994; Eliopoulos et
al, 1995; Rusch et al, 1995; Marks et al, 1996). However, in many
instances, drug concentations in patient serum are less than those
used in the laboratory. Thus, in common with others, we studied
death oflymphoblastoid cells within hours ofexposure to 5 gM (or
more) etoposide (Catchpoole and Stewart, 1993); clinical concen-
trations ofthis drug are typically 0.05 ,UM and rarely exceed 0.5 ,UM
(Mross, 1996). Different pathways to cell death, dependent upon
drug concentration, have been discerned (Del Bino et al, 1991;
Lock et al, 1994; Tomaletti and Pfeifer, 1995; Jordon et al, 1996).
In experimental cell populations exposed to drug concentrations
which cause G2/M arrest, the mode of cell death has been
perceived to be distinct from classic apoptosis and, in some such
cases, the term mitotic death has been proposed (Chang and Little,
1991; Demarcq et al, 1994; Ormerod et al, 1994; Dou et al, 1995;
Bonelli et al, 1996). We have sought to investigate this mode of
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cell death using two lymphoblastoid cell lines CCRF-CEM (CEM)
and MOLT-4 that have been exposed to etoposide concentrations
between one and two orders of magnitude less than that which
causes immediate cell death. A particular focus was the emergent
hypothesis that, during apoptosis, intemucleosomal cleavage may
be accompanied by higher order fragmentation ofDNA.
Detection ofDNA fragments of50 kb or more by pulse-field gel
electrophoresis (PFGE) after exposure of cells to etoposide was
initially interpreted with reference to the location oftopoisomerase
II (Filipski et al, 1990). Subsequently, the same effect was associ-
ated with apoptosis causedby avariety ofstimuli, including agents
not associated with direct damage to DNA (Brown et al, 1993;
Oberhammer et al, 1993; Cohen et al, 1994; Desjardins and
MacManus, 1995).
In the present study, we monitored genomic fragmentation by
both conventional and PFGE and examined its relationship to
changes in gene expression after treatment with etoposide at both
high (5 gM) and low (0.5-0.05 gM) concentration. Many cell types
undergo differentiation when exposed to cytotoxic drugs at low
concentration, and the contribution of induced differentiation to
induction of programmed cell death remains uncertain (Warrell,
1997). Specifically in relation to T cells, progressive differentia-
tion is associated with increased susceptibility to apoptosis and
correlated with gradual loss of bcl-2 and gain of Fas expression
(Salmon et al, 1994). T-cell differentiation is marked by sharp
changes in the expression of purine metabolic enzymes including
purine nucleoside phosphorylase (PNP) (Ma et al, 1983) and such
change is induced by phorbol esters (Martinez-Valdez and Cohen,
1988). Consistent with the intimate relationship between normal
and malignant lymphoid cells (Campana and Janossy, 1988),
altered expression of genes associated with purine metabolism is
induced in CEM cells by phorbol 12-myristate 13-acetate (PMA)
(Madrid-Marina et al, 1990). In preliminary experiments, we
compared PMA with etoposide and established that drug-induced
changes in PNP and terminal deoxynucleotide phosphorylase
preceded and were more marked than altered adenosine
deaminase expression. On this basis, we have contrasted the effect
of etoposide with that of PMA in relation to PNP expression and
other parameters including morphological change and genomic
fragmentation.
After exposure to etoposide at high concentration, changes in
50-kb cleavage of DNA, gene expression and cell cycle progres-
sion were all evident within 6 h and not only occurred simultane-
ously but also coincided with morphological change and altered
membrane permeability. Experiments with etoposide at low
concentration revealed a more informative scenario. Sequential
change may be discerned, providing a means for establishing rela-
tionships between classic apoptosis and cell death after G2/M
arrest. In this context, 50-kb fragmentation of DNA is established
as a sensitive indicator of commitment to the cell death/apoptotic
pathway and may be clearly shown to precede intemucleosomal
fragmentation, which occurs coincident with morphological
evidence ofcell death.
MATERIALS AND METHODS
Cell biology
MOLT-4 and CEM cell lines were maintained in RPMI-1640
medium supplemented with 2 mM L-glutamine and 10% fetal bovine
serum (Biosciences Pty, Australia) at 370C. Cells in logarithmic
growth were treated with etoposide (Sigma Chemicals, St Louis,
MO, USA) in dimethyl sulphoxide (DMSO, final concentration,
0.05%), the vehicle alone being added to control cultures. Cell
numbers were determined by phase-contrast light microscopy using
a haemocytometer. Procedures for treatment and harvesting have
been described (Catchpoole and Stewart, 1993).
Morphological analysis
Cytospin preparations were made with 100-gl (4 x 105 cells)
aliquots and stained using Wright's solution (Catchpoole and
Stewart, 1993). Morphological assessment was made by light
microscopy. Quantification ofspecific lesions was made by exam-
ination of at least 150 cells per field from at least three separate
experiments and the result was expressed as the mean percentage
ofcells exhibiting the structure specified.
Reverse transcriptase polymerase chain reaction
(RT-PCR)
Total cytoplasmic RNA was isolated (Chomczynski and Sacchi, 1987)
and reverse transcribed using Maloney murine leukaemia virus DNA
polymerase and random hexanucleotide primers (Noonan et al, 1990).
Gene-specificprimersforPNP(sense: 5'-ATGCAGCAGGAGGGCT-
GAAC-3'; antisense5'-AGGCATCAGACATGGCAGGG-3'; product
length, 153 nucleotides) and glyceraldehyde-3-phosphate dehydro-
genase (GAP) (sense: 5'-TGGGGAAGGTGAAGGTCGGA-3'; anti-
sense 5'-TGGTGCAGGAGGCATTGCTG-3'; product length, 110
nucleotides) were used to co-amplify target mRNA sequences in a
competitive PCR reaction essentially as described by Bordow et al
(1994), including primer design to negate possible DNA contamina-
tion of the original isolate and the establishment of a cycle number
corresponding to linear incorporation. A cDNA amount equivalent to
40 ng RNA was subjected to PCR for 35 cycles in a final volume of
25gl using 1 unit of AmpliTaq Polymerase. The optimized reaction
conditions involved an initial denaturation at 94°C: each cycle
consisted of45 s at 94°C, 45 s at 55°C and 90 s at 72°C. After PCR,
aliquots (10 1) were subjected to 12% polyacrylamide gel electro-
phoresis before ethidium bromide staining and photography. To
quantitate product formation after competitive PCR, photographic
negatives were densitometrically scanned (Hoeffer GSV300
Australian Chromatography, Sydney, Australia) and a ratio between
target andcontrol PCR products was determined foreach sample.
Flow cytometry
Cell cycle distribution was determined by flow cytometry after
propidium iodide staining (Deitch et al, 1982), as described previ-
ously (Catchpoole and Stewart, 1993). Using red propidium-DNA
fluorescence, 10 000 events were acquired with a FACScan
cytometer and analysed using LYSIS II and Cellfit software
(Becton Dickinson, San Jose, CA, USA).
Agarose gel electrophoresis
Internucleosomal DNA breakage was detected using conventional
agarose gel electrophoresis after isolation of DNA as follows.
Cells (2 x 106) were washed in phosphate-buffered saline (PBS) by
centrifugation at 10 000g at 4°C for 5 min. Cell pellets were lysed
in 200 p1 ofDNAzol (Molecular Research Centre, Cincinnati, OH,
USA) by gently pipetting the suspension. RNAase A was added
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RESULTS
6.0-I
E
5.51
0 10 20
Time (h)
Figure 1 The relationship between etoposide c
CEM and MOLT-4 cells. At time zero, etoposide
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to the medium of CEM (closed symbols) or MOL
cell numbers for up to 48 h in the presence of thE
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24 h because of cellular debris and cytolysis
We have previously examined the response of CEM and MOLT-4
cells to etoposide in terms of internucleosomal fragmentation
of DNA, cell cycle distribution and morphological change
(Catchpoole and Stewart, 1993; 1995). A feature ofthese data was
the difference between the two cell populations. In studies using
*7 5-100 GUM etoposide, CEM cells exhibited 'classic' apoptosis,
whereas internucleosomal fragmentation and apoptotic bodies
were not evident in the MOLT-4 population. Moreover, although
the drug was equally cytotoxic in both lines, loss of membrane
30 40 S integrity appeared to have different kinetics. Despite these differ-
ences, there was a uniformity in response ofboth the CEM and the
MOLT-4 populations: exposure to etoposide caused immediate
,oncentration and growth of
at final concentrations of apoptotic cell death as determined by morphological criteria. The
le), 5 gM (circle) was added response was independent of drug concentration: if this were
T-4 cells (open symbols) and reduced from 100 ,UM to 5 m,M apoptosis was still evident within
a drug were contrasted with 6 h. The present data indicate that this is not the case if the etopo- iares). At the highest
d not be determined beyond side concentration is reduced by one further order of magnitude.
Whereas exposure to 0.5 ,UM etoposide causes cell death in both
CEM and MOLT-4 cells, this lesser concentration is associated
with an altered response such that cell death is preceded by
(30 ,l of a 10 mg ml-' stock) and the suspension incubated for
30 min at 37'C and further centrifuged for 10 min at 10000 g at
4°C. After centrifugation, the viscous supernatant was transferred
to a fresh tube. DNA was precipitated by addition of 100,l cold
100% ethanol and pelleted by centrifugation for 30 min at
10 000 g at 4°C. The resulting DNA precipitate was washed twice
with 800gl of 95% ethanol and allowed to air dry for 30 min at
room temperature before resuspending in 80,l of 8 mm sodium
hydroxide buffered with 2,l 1 M Hepes (N-2-hydroxyethylpiper-
azine-N'-2-ethanesulfonic acid; final pH 7.2) and subjected to
electrophoresis in 1.8% agarose (Catchpoole and Stewart, 1993).
PFGE
Cells (5 x 106) were resuspended in 60gl ofcell suspension buffer
(10 mm Tris, pH 7.2, 20 mm sodium chloride, 50 mM EDTA) and
allowed to equilibrate at 50°C. The suspension was gently mixed
with 37 ,l of pre-warmed (50°C) '2% Clean Cut Agarose' (Bio-
Rad, Hercules, CA) and the mixture immediately transfered to plug
moulds (using sterile transfer pipettes) and incubated at 4°C for
20 min to expedite agarose solidification. Agarose plugs were then
subjected to proteinase K digestion by the addition of 500gl of
100 mM EDTA, pH 8.0, 0.2% sodium deoxycholate, 1% sodium
lauryl sarcosine solution containing 40 gg ml-' proteinase K and
incubated at 50°C overnight. Plugs were washed for 1 h (x 4) in
wash buffer (20 mM Tris, pH 8.0, 50 mM EDTA) at room tempera-
ture with gentle agitation and stored in 0.1 x wash buffer at 4°C
before electrophoresis. Samples, including a DNA molecular
weight standard (48.5 kb lambda ladder, Bio-Rad), were electro-
phoresed through 1% pulsed field gel grade agarose in a horizontal
electrophoresis system (model CHEF-DR-III; Bio-Rad
Laboratories). The run parameters included aramped switch time of
50-90 s over 22 h at 6 V cm-' across an included angle of 1200 in a
0.5 x TBE (89 mm Tris-HCl, 89 mm sodium borate, 2 mM EDTA
pH 8.3) buffer system. The buffer was allowed to recirculate contin-
uously and the temperature maintained at 14°C using a cooling
changes not evident using the high concentration range previously
studied.
Growth patterns
As determined by MTT cytotoxicity assay (72-h exposure), CEM
and MOLT-4 cells are equally sensitive to etoposide, theID50 being
approximately 0.05 ,UM (Catchpoole and Stewart, 1993). The
determination of cell number up to 48 h after addition of the drug
provided further evidence that the two lines were equally sensitive.
In relation to an effect on cell number, no adverse effect was
apparent in either population after the addition of 0.05 gM etopo-
side. Stasis in cell number overthe incubation period was achieved
using 0.5 ,UM etoposide (Figure 1) and a sharply decreased number
ofcells was evident after the addition of 5 ,UM etoposide.
Morphology
Light microscopic examination was made ofcells exposed to either
etoposide or PMA. In the case of the phorbol ester, no treatment-
related changes were apparent in CEM (Figure 2A and E) or
MOLT-4 cells (data not shown). Morphological evidence of cell
death is obvious 6-12 h after exposure ofCEM cells to 5 gM etopo-
side (Figure 2F). In contrast, light microscopic examination ofcells
exposed to 0.5 gM or 0.05 ,UM etoposide for up to 24 h revealed
minimal evidence of injury and cell death. There was progressive
accumulation of darkly staining nuclei indicative of dividing cells
after the addition of etoposide. In addition, the drug-treated cells
could be distinguished from appropriate controls because cyto-
plasmic vacuoles were more common in cells exposed to etoposide
(Figure 2A-C and G). When incubation was continued from 24 to
48 h, a marked change was immediately obvious. Cell death and
associate debris were prominent to the point of obscuring any
unaffected cells. Lesions specifically associated with apoptosis
were evident: condensed chromatin, apoptotic bodies and
secondary necrosis (Figure 2D and H). Multipolar mitotic figures
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Figure 2 The appearance of CEM cells after exposure to etoposide and PMA. Wright-stained cytospin slide preparations were prepared after exposure to
0.5gM etoposide for 12 (B), 24 (C) and 48 h (D), 5gM etoposide for 12 h (F) and to 0.05gM etoposide for 24 (G) and 48 h (H). Etoposide-induced morphological
change may be discerned by comparison with vehicle control cells (0.05% DMSO for 24 h; A) and cells exposed to 10 nm PMA for 12 h (E). Morphological
features evident include mitosis (M), cytoplasmic vacuoles (CyV) as well as change specifically indicative of cell death, including cytoplasmic protrusions (CyPr),
apoptotic bodies (ApB), condensed chromatin (Ccr), primary necrosis (1ON) and secondary necrosis (20N), these terms identifying lysis of whole cells and
apoptotic bodies respectively
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Table 1 Quantification of morphological change induced by 0.5gM etoposide
Treatment Cytoplasmic Cytoplasmic Marginated Secondary
time vacuoles protrusins condensed necrosis
(h) chromatin
CEM
Vehicle control 4.0 ± 0.4a 1.6 + 0.6 0.9 ± 0.2 4.2 ± 1.5
3 8.4 ± 1.9 3.3 ± 1.0 1.6 ± 0.6 2.4± 0.4
6 8.8±0.96 5.1 +0.6 3.1 ±0.9 3.8 ± 1.8
12 7.5 ± 0.6 6.0 ± 0.8 4.2 ± 1.5 2.4 ± 0.6
24 21.1 ± 6.1 5.3 ± 1.0 4.7± 2.1 5.1 ± 1.8
48 81.3± 3.1 >90b > 90 55.3± 2.8
MOLT-4
24 16±3.1 6.0± 1.0 1.1 ±0.5 2.5±0.9
3 5.8 ± 1.7 3.8 ± 0.9 3.1 ±1.5 2.9 ± 1.6
6 6.4 ± 0.6 3.1 ±1.2 3.3± 1.4 1.3 ± 1.0
12 7.3 ± 1.4 5.1 ±1.6 6.9±1.6 4.9 ± 1.2
24 12.4±1 6.7±1.4 12.7±2.7 3.8±0.60
48 >90 >90 >90 18.7±2.5
aThe percentage of cells exhibiting each lesion was quantified as described in Materials and methods. bThis
result indicates that the result could not be precisely quantified because the majority of cells exhibited the lesion
and cell debris precluded quantification.
were not seen. Cell debris limited detailed analysis and there was
little distinction between preparations exposed to 0.5 and 0.05 gM
etoposide. Essentially the same results were observed in similar
preparations ofMOLT-4 cells (data not shown).
Quantification ofcells exhibiting various morphological lesions
characteristic ofapoptosis established that exposure ofeitherCEM
or MOLT-4 cells to 0.5 gM etoposide for up to 24 h rarely caused
cell death. After such treatment, the number of cells containing
vacuoles was increased, but no increase in the number of non-
viable cells was evident in MOLT-4 or CEM preparations exposed
to 0.5 gM etoposide for 24 h (Table 1). By comparison, the radical
change in morphology consequent upon exposure ofthese cells to
0.5 gM etoposide for 48 h effectively precluded summation of
discrete lesions: cell debris and secondary necrosis obscured many
of the remaining cells, limiting quantitation to estimates only
(Table 1).
Gene expression
Increased expression of PNP was evident 6 h after exposure of
CEM or MOLT-4 cells to 10 nM PMA. By the same criterion, i.e.
quantification relative to expression of GAP using RT-PCR
(Figure 3), a marked increase (greater than three-fold in terms of
the arbitary units used) in the expression of PNP was recorded in
CEM cells exposed to 0.5,M etoposide and this increase was
sustained till at least 12 h after the addition of the drug. Similar
results were recorded using MOLT-4 cells (data not shown). When
the concentration of etoposide was reduced to 0.05 gM, a similar
induction of PNP occurred. Moreover, such altered PNP expres-
sion could not be distinguished from that occurring in cells
exposed to 5 gM etoposide (Figure 3).
Cell cycle
In contrast to the pattern of similarly increased expression of the
marker gene PNP over the dose range 0.05-5 gM etoposide, a
sharp demarcation was apparent when flow cytometry was used to
assess cell cycle distribution. Earlier studies had involved 5 ,UM
etoposide, and indicated that 3 or 6 h after the addition ofthe drug
to the medium there was a slight increase in the proportion ofG,
cells. Even when such cultures were analysed after 24 h, cell cycle
distribution within the small fraction of surviving cells exhibited
no increase (relative to vehicle-treated controls) in the proportion
of cells at G2/M. In contrast, etoposide in the concentration range
0.5 gM-0.05 gM resulted in cell cycle arrest such that by 24 h the
proportion of cells at G2/M was three- to fivefold greater than in
the untreated population (Figure 4). No change in cell cycle
distribution of either CEM or MOLT-4 cells was evident after the
addition of0.005 gM etoposide.
Genomic fragmentation
PFGE was used to examine higher order fragmentation of DNA
from CEM and MOLT-4 cells exposed to PMA and etoposide. In
addition to causing differentiation (Madrid-Marina etal, 1990), the
exposure of leukaemic cells to PMA has been reported to cause
internucleosomal fragmentation ofDNA (Ohta et al, 1995). In our
studies, no higher order fragmentation of DNA was evident by
PFGE using DNA isolated from CEM or MOLT-4 cells exposed
10 nM PMA or after exposure to DMSO at vehicle-control
concentration. However, such fragmentation was detected in DNA
isolated from either cell line after the addition of etoposide to the
media. Specifically, in preparations from MOLT-4 cells, broad
bands corresponding to approximately 50-150-kb were observed
6 h after the addition of 5 or 50gM etoposide although, as previ-
ously described, internucleosomal fragmentation of DNA was not
detected under the same conditions.
Over the broad etoposide concentration range studied (50-
0.05gM), PFGE data involved bands of various intensity, but
corresponding to a limited size range. Most bands were 50 kb, but
variation to 150 kb occurred. This was common to both lines. No
consistentpattern forthis slightvariation in size range was apparent:
no progression from 150 kb to 50 kb with increasing treatment time
was recorded, and no progression over the 50-150-kb range within
increasing or decreasing concentration of etoposide could be
discerned. Moreover, repeat experiments indicated that identical
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Figure 3 RNA isolated from control and drug-treated CEM cell preparations
was reverse transcribed and subject to competive RT-PCR analysis as
previously described (Bordow et al, 1994). (A) A representative RT-PCR gel
showing changes in PNP expression (upper band) after 0.5gM etoposide
treatment in CEM after 3, 6, 12, 24 and 48 h exposure (lanes 4 to 8
respectively) compared with vehicle control (lane 1). Preparations
corresponding to phorbol ester (10 nm PMA)-treated samples isolated after 6
and 12 h are in lanes 2 and 3 repectively. After densitometric analysis of the
PCR products, the relative intensity shown is the ratio between the target
gene PNP and the housekeeping gene GAP (lower gel band). (B) Pro-
gressive change in expression of PNP after treatment of CEM cells with
0.05 gM (U), 0.5gM (*) and 5lM (0) etoposide. Each point is the mean
relative expression based upon at least two experiments. The inset shows
relative changes in PNP expression after 10 nm PMA treatment
treatment conditions involved fluctuation within the size range indi-
cated. Such variation is often (Cohen et al, 1994; Zhivotovsky et al,
1994; Weis et al, 1995) but not invariably (Brown et al, 1993;
Oberhammer et al, 1993; Beere et al, 1995) seen in similar PFGE
analyses.
When the various etoposide concentration/exposure time
combinations were assessed, the results from CEM and MOLT-4
cells were similar (Figure 5). After exposure to etoposide at high
concentration (5 or 50giM), 50-150-kb fragmentation ofDNA was
evident. Such breakage was detected 6 h after the addition of the
drug and a similar result was recorded up to 24 h after the addition
of 5 gM etoposide. It was not possible to make PFGE analysis at
such times after 50 ,UM etoposide because complete cellular
destruction precluded recovery of DNA. Such 50-kb breakage of
DNA was not evident in preparations isolated 3 or 6 h after the
addition of0.5 or 0.05 ,UM etoposide. It was, however, consistently
detected in DNA isolated 12 h, and most markedly observed in
DNA isolated 24 h after the addition of the drug at these concen-
trations (Figure 5). These findings were equally clear in both
MOLT4 and CEM cells.
Data from multiple PFGE studies are summarized in Table 2.
Among other considerations, data from both cell lines indicate that
results using a single exposure time would be inadequate to assess
higher-order fragmentation of DNA caused by etoposide, the 6 h
Etoposide concentration (gM)
Figure 4 The proportion of cells at G/M after 24 h continuous exposure to
etoposide. After drug treatment, CEM (U) and MOLT-4 cells (1!), cell cycle
distribution was determined by flow cytometry and the proportion of GIM
expressed as a percentage. Typical flow cytometric profiles, specifically
involving 6 h exposure to 5 gM, 17gM and 100gM etoposide have been
published (Catchpoole and Stewart, 1993). Results shown are the means of
at least two experiments, except for 0.005 gM etoposide which records a
single study
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Figure 5 PFGE analysis of DNA from cells exposed to 0.05-50gIM
etoposide. DNA from MOLT-4 (A) and CEM (B) cells was subject to PFGE
and ethidium bromide fluorescence is presented as a photographic negative.
For A, DNA was isolated from untreated cells (lane 1), cells exposed to
etoposide for 3 h at concentrations of 0.05 ,iM, 0.5gM and 5 ,UM (lanes 2-4),
for 6 h at 0.05 ,UM, 0.5 iM and 5lM (lanes 5-7), for 12 h at 0.05gM and
0.5 ,iM (lanes 8 and 9). DNA was also isolated from cells exposed to 50 gM
etoposide for 3 h and 6 h (lanes 11, 12). Preparations from CEM cells (B)
correspond to untreated (lane 1), DMSO vehicle control for 24 h (lane 2),
10 nM PMA for 6 and 12 h (lanes 3, 4), 0.05gM etoposide for 6, 12 and 24 h
(lanes 5-7), 0.5,iM etoposide for 12, 24 and 48 h (lanes 8-10) and 5gM
etoposide for 6 h (lane 11). Markers were run in lanes indicated (M), with the
50-kb marker band indicated on the left of each panel
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Table 2 Etoposide-induced 50 kb and internucleosomal cleavage in CEM
and MOLT-4 cells
Etoposide concentration (gM)
Exposure time 0.05 0.5 5 50
CEM
3 a - + ±(L)
6 + + +(L)b ++(L)
12 + + ++(L) DNAc
24 ++ ++ ++(L) GNA
48 - ++(L) GNA GNA
MOLT-4
3 - - - +
6 - - + ++
12 + + ++ QNA
24 + + QPJA 4NA
48 Not done ++ QNA QNA
aSummary results of multiple PFGE of DNA from cells exposed to etoposide
are summarized using ++ to indicate the most intense band for the drug
concentration used, + for consistent bands of lesser intensity, ± for results in
which 50-kb bands were observed in some but not all analyses of DNA for
the exposure time/etoposide concentration indicated and - to indicate non-
detection of 50-kb breakage. Each result is indicative of at least two, and
usually three or more analyses involving separate expenments. bDNA
isolated from the same cells was subjected to conventional agarose gel
electrophoresis and (L) indicates those protocols causing ladders; for all
other samples, internucleosomal fragmentation was not detected. QNAc
indicates non-availability of DNA consequent upon complete cellular
destruction after prolonged exposure to the drug at high concentration.
Figure 6 Analysis of etoposide-induced internucleosomal DNA
fragmentation by 1.8% agarose gel electrophoresis. DNA was isolated from
CEM cells after 24 h exposure to 0.05% DMSO (lane 1), 12 and 24 h
exposure to 0.2gM etoposide (lanes 2 and 3); 12, 24 and 48 h exposure to
0.5gM etoposide (lanes 4-6) and after exposure to 5gM etoposide for 12 and
24 h (lanes 7 and 8). Internucleosomal fragmentation formation is evident in
lanes 6-8. The corresponding analyses using DNA isolated from MOLT-4
cells revealed no evidence of internucleosomal fragmentation
time point, for example, being appropriate to high concentrations
but failing to detectpositive results from lowerdrug concentrations.
Whereas PFGE analysis of DNA from CEM and MOLT-4
cells yielded similar results, the two lines differ most markedly in
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Figure 7 Cell death, as indicated by trypan blue staining, of CEM cells after
continuous exposure up to and including 48 h to 0.005-50gM etoposide.
Results are expressed as the means of at least two studies. Similar results
were obtained using MOLT-4 cells
relation to intemucleosomal fragmentation. We have described the
absence ofDNA ladders afteretoposide treatment ofMOLT-4 cells
(Catchpoole and Stewart, 1993). Under the same conditions (i.e.
high etoposide concentration), the occurrence of intemucleosomal
fragmentation in DNA from CEM cells is coincident with 50kb
breakage, i.e. it is evident 3-6 h after treatment. In contrast, DNA
ladders were not detected 3, 6, 12 or 24 h after treatment with
0.5 ,UM etoposide, but were evident in DNA isolated48 h after such
treatment (Figure 6). Ladders were not detected in any DNA prepa-
rations from cells exposed to 0.05gM etoposide. To facilitate direct
comparison with PFGE data, these findings have been included in
the section ofTable 2 corresponding to CEM cells.
Trypan blue
Delayed loss ofmembrane integrity is arecognizedcharacteristic of
apoptosis. In common with many ofthe otherbiological parameters
studied, staining of CEM or MOLT-4 cells exposed to etoposide
over a wide concentration range indicated two responsepatterns. At
high etoposide concentrations (50 or 5 gM), approximately one-
quarter of CEM cells were stained after 6 h, with the entire treated
population showing uptake by 24 h. Staining ofMOLT-4 cells after
the same treatment was similar (i.e. immediately and progressively
increasing), with all cells permeable to the dye by 48 h. A different
response pattern was observed at lower drug concentrations. When
etoposide concentration was decreased from 5 gM to 0.5 gM, a
notable increase in trypan blue uptake was not evident before the
48-h time point, when 70% ofcells were stainedpositive (Figure 7).
A similar pattern was evident using 0.05 gM etoposide, although in
this case only one-third of cells were killed by 48 h. Exposure of
cells to 0.005 gM etoposide had no significant effect on viability by
this criterion. Trypan blue staining of MOLT-4 cells exposed to
0.5 JM or lowerconcentration ofetoposide yielded aresult (data not
shown) virtually identical to that recorded for CEM cells. In partic-
ular, positive staining ofMOLT-4 cells exposed to 0.5 JM etoposide
was only observed in the majority ofthe population after48 h expo-
sure, and not at earlier times.
British Journal ofCancer(1998) 77(1), 40-50 0 CancerResearch Campaign 1998Kilobase DNA breaks during cell death afterG2/M arrest 47
DISCUSSION
Despite the use of DNA ladders as a 'hallmark' of apoptosis, this
lesion is not observed during apoptosis induced by a variety of
stimuli (Barres et al, 1992; Oberhammer et al, 1922), and specifi-
cally including cytotoxic drugs in some situations (Bertrand et al,
1991; Hotz et al, 1992; Catchpoole and Stewart, 1993; Falcieri et
al, 1993). Although it is generally accepted that cytotoxic drugs
elicit apoptosis via a 'final common pathway', there have been few
molecular criteria apart from DNA ladders to characterize this
process (Lennon et al, 1991; Marks and Fox, 1991). Relatively
recently, however, higher-order fragmentation of DNA as
evidenced by PFGE has been widely reported in cells during
classic apoptosis (Bortner et al, 1995). Moreover, Hickman and
colleagues (Beere et al, 1995) were able to distinguish between
DNA breakage attributable to stabilization of topoisomerase II
cleavable complex and higher-order fragmentation of DNA not
associated with this mechanism. Not so readily summarized are
findings on the relationship ofhigher-order breakage to internucle-
osomal fragmentation and to morphological change indicative of
apoptosis. Our data, which contribute insight in relation to both
these issues, were generated in the course ofinvestigating whether
a mode of cell death distinct from apoptosis could be characterized
in lymphoblastoid cells exposed to etoposide at low concentration.
The study was prompted by the observation that apoptotic
morphology and intemucleosomal fragmentation of DNA were
not evident 6 or 24 h after incubation of CEM cells with 0.5 gM
etoposide (Stewart et al, 1995), as distinct from positive findings
using S ,UM, 17 gM or higher concentration etoposide (Catchpoole
and Stewart, 1993). The findings appeared to support the conclu-
sion reached by Ormerod et al (1994): namely that cisplatin-
induced cell death of L1210 cells after G2/M arrest should not be
classified as apoptosis.
Whereas treatment of CEM and MOLT-4 with 5 gM etoposide
caused cell death within hours (Catchpoole and Stewart, 1993)
(see also Figure 2F) and a commensurate decrease in cell number,
0.5 gM etoposide caused a cytostatic effect (Figure 1). A growth
response, involving murine fibroblast monolayers exposed to
0.1-10.0 gM etoposide, almost identical to that shown in Figure 1
was recently described by Bonelli et al (1996), although their
study involved cell death at the two higher concentrations (i.e. 1.0
and 10 gM). In our study, histological evaluation indicated that
despite the absence of any net decrease in total cell number
(Figure 1), cell death occurred 48 h after exposure to 0.5 gM (or
more) etoposide (Figure 2), the consistent cell number being
attributable to some proliferative activity. Although a further
decrease in drug concentration to 0.05 gM resulted in no effect
on cell number by comparison with vehicle-treated controls,
drug-induced cell death was again evident after light microscope
examination (Figure 2).
Morphological evidence of cell death 48 h after exposure to
0.05 gM etoposide (Figure 2) indicates the limitation of cell count
(Figure 1) as an immediate indicator of severe injury at low drug
concentrations. Cell count does not differentiate between viable
and non-viable (i.e. trypan blue positive) cells, the latter making
up an increasing portion of the treated population (Figure 7). The
data suggest that 48 h after the addition of 0.05 gMetoposide, dead
and dying cells are still intact during phase contrast microscopy
(for cell count), but rupture during cytospin preparation. Such
fragmentation might give the appearance of necrosis despite the
cell being commited to an apoptotic pathway.
The complex relationship between cellular proliferation, differ-
entiation and apoptosis is indicated among other things by the
differentiating effect ofanti-cancerdrugs at non-cytotoxic concen-
tration (Constantinou et al, 1992; Schwartz et al, 1992; Li et al,
1995; Grant et al, 1996). Altered expression of genes associated
with lymphocyte differentiation (Ma et al, 1983; Madrid-Marina
et al, 1990) may have indicated a differential response in which
lower etoposide doses were more closely associated with differen-
tiation. However, the data (Figure 3) indicate that an immediately
lethal concentration ofetoposide (5 gM) caused an increase in PNP
expression similar to that which occurred using concentrations
100-fold less. This response was similar to, if not more marked
than that induced by PMA. In relation to etoposide concentration,
similar induction of PNP precludes using this effect to identify
different response pathways. Moreover, induction of PNP
occurred within a similar time frame and there was no delay asso-
ciated with lower concentrations of etoposide. Thus, a conspic-
uous feature of altered PNP expression is its immediacy. Of the
biological parameters analysed (cell cycle progression, genomic
fragmentation, dye uptake, etc.), monitoring gene expression
revealed the earliest response to drug treatment.
After studying death of murine leukaemic cells induced by
cisplatin, Eastman and colleagues (Sorenson et al, 1990) described
two pathways: one involving a rapid, direct nuclease activation
induced by very high drug concentrations and the other necessi-
tating G2/M arrest before cell death. This relationship appears to
be common. Etoposide and similar agents have been variously
reported to cause eitherGI (Chen et al, 1995; Dou et al, 1995; An
and Dou, 1996) or G2/M arrest (Rao and Rao, 1976; Chow and
Ross, 1987), the difference being attributable, in the first instance,
to drug concentration (Del Bino et al, 1991; Touneki et al, 1993).
After the addition of 0.5 gM etoposide to CEM or MOLT-4 cells,
the proportion ofcells at G2/M increased progressively in determi-
nations made between 6 h and 24 h later, when a maximal value
was recorded (data not shown). This response pattern involved a
specific etoposide concentration range (Figure 4). However,
although G2/M arrest may precede drug-induced cell death in a
variety of circumstances, the relationship between these effects
varies. Thus, Schimke et al (1995), studying cell death after drug-
induced G2/M arrest in HeLa cells, describe aberrant mutipolar
mitoses. However, we observed no such structures in the course of
the present study. During drug-induced death of HeLa cells after
mitotic block, internucleosomal fragmentation of DNA has been
detected in some circumstances (Jordon et al, 1996) and not in
others (Lock and Stribinskiene, 1996). DNA ladders were not
evident during etoposide-induced death ofmurine fibroblasts after
G2/M arrest (Bonelli et al, 1996). More relevantly, absence of
ladders was noted in L1210 leukaemic cells aftercisplatin-induced
G2/M arrest (Ormerod et al, 1994). The present findings include
detection of DNA ladders 48 h after the addition of 0.5 gMetopo-
side to CEM cells but not in MOLT-4 cells (Figure 6), although all
our other findings suggest the mode of etoposide-induced cell
death in these two populations is the same. In fact, the diverse
observations summarized aboveprovide no basis forestablishing a
relationship between G2/M arrest and cell death. However, at least
in respect of the present data, a relationship may be proposed by
reference to the PFGE results.
Reviewing the description ofhigher-order fragmentation during
apoptosis in many contexts, Cidlowski and colleagues (Bortner
et al, 1995) commented that more studies were needed to deter-
mine whether higher-order fragmentation is indeed a universal
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characteristic of apoptosis. As MOLT-4 cells were significant in
demonstrating the limitations of DNA ladders as a molecular indi-
cator of apoptosis (Hotz et al, 1992; Catchpoole and Stewart,
1993; Falcieri et al, 1993), detection ofhigher-order fragmentation
in these cells after exposure to etoposide is noteworthy. Such a
result was reported by Beere et al (1995) using 50 gM etoposide. It
is now evident that concentrations of the drug 1000-fold less may
induce the same effect in these cells, albeit after a markedly
different exposure time (Figure 5). Our studies indicate no differ-
ence in sensitivity for 50-kb breakage between MOLT-4 and CEM
cells. The two lines are equally sensitive to the drug [(Catchpoole
and Stewart, 1993) and Figure 1] and this is consistent with virtu-
ally identical dose-response patterns for 50-kb fragmentation.
After the exposure of CEM or MOLT-4 cells to 5 gM etoposide,
the appearance of50 kb fragments (Table 2) is virtually coincident
with topoisomerase II-mediated single-strand breakage, produc-
tion of DNA ladders and histological evidence of cell death
(Catchpoole and Stewart, 1993). In each of the lines exposed to
either 0.5 gM or 0.05 gM etoposide, higher-order DNA fragmenta-
tion was detectable by PFGE after 12 h, although there was no
morphological evidence of cell death at that time (Table 1, Figure
2). Under these conditions, 50-kb breakage coincided with G,/M
arrest. The inability to detect ladders 24 h after the exposure of
CEM cells to 0.5 gM etoposide was a consistent finding. However,
48 h after the addition of 0.5 gM etoposide, loss of membrane
integrity was clearly evident in both lines (Figure 7) and DNA
ladders were evident in CEM cells (Figure 6). The separate genesis
of 50 kb and intemucleosomal fragments, respectively, is com-
patible with other reports of higher-order fragmentation in the
absence of DNA ladders (Oberhammer et al, 1993; Watanabe et al,
1995) and evidence that, in thymocytes, nuclease activity medi-
ating cleavage of DNA into large fragments is distinguished from
that causing ladders (Sun and Cohen, 1994; Walker et al, 1994).
It is evident from the present findings that DNA ladders are a
limited, if not an inadequate vehicle to establish a specific mode
of cell death. As exemplified by MOLT-4 cells, ladders are not
observed when all other criteria of apoptosis, including 50-kb
breakage, are apparent. More critically, as exemplified by CEM
cells, ladders are an insensitive analytical tool that are observed in
a narrow range, both in terms of time and drug concentration,
compared with higher-order fragmentation. The remarkably
restricted dose/time distribution of ladders (L) in Table 6 suggests
that at least some reports concerning absence ofthis lesion in death
after G./M arrest involve missing the narrow 'window' at which
DNA ladders appear. Finally, in the experimental system described
here, DNA ladders are coincident with, and do not precede
membrane and morphological evidence of cell death, confirming
their status as a post-mortem event (Vaux and Strasser, 1996).
None of these limitations apply to 50-kb fragmentation ofDNA.
Higher-order fragmentation of DNA, and specifically genera-
tion of50-kb breaks, has been associated with apoptotic cell death.
The present results using 5 gM etoposide provide further evidence
for such an association in the case ofCEM cells and, in the case of
MOLT-4 cells, indicate that such breakage may occur more gener-
ally than another indicator, namely DNA ladders. Processes asso-
ciated with drug-induced apotosis have been characterized in
systems exemplified by treatment of these two lines with S gUM
etoposide: cell death occurs in 4-8 h. Drug-induced cell death may
also occur over a wider timeframe, and specifically after G2/M
arrest. An argument has been made that such cell death occurs by
processes that distinguish it from apoptosis. Our findings mitigate
caution in this regard. First, apoptotic indicators (typified by DNA
ladders in this study) may be not so much absent as difficult to
detect in a broader timeframe. Second, certain indicators (commit-
ment to differentiation and 50-kb DNA breakage) were observed
by us to be common to apoptotic cell death and to cell death after
G2/M arrest. Moreover, in the latter circumstances, 50-kb DNA
breakage clearly precedes both DNA ladders and morphological
change by light microscopy. Finally, in etoposide-treated CEM and
MOLT-4 cells, 50-kb DNA breakage is best characterized as being
coincident with G,/M arrest rather than a consequence of it. This
mode of cell death seems closely related to apoptosis, but may be
particular to haematopoietic cells.
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